For filings with the FSA include the annexFor filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii
ANIMALCARE GROUP PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii
HARGREAVE HALE LIMITED
4. Full name of shareholder(s)
(if different from 3.):iv
DISCRETIONARY CLIENTS
5. Date of the transaction and date on
which the threshold is crossed or reached: v
20 JULY 2011
6. Date on which issuer notified:
21 JULY 2011
7. Threshold(s) that is/are crossed or reached: vi, vii
5%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares
if possible using
the ISIN CODE
Situation previous
to the triggering transaction
Resulting situation after the triggering transaction
Class/type of
shares
if possible using
the ISIN CODE
Number
of
Shares
Number
of Voting Rights
Number
of shares
Number of voting
rights
% of voting rights
x
Class/type of
shares
if possible using
the ISIN CODE
Number
of
Shares
Number
of Voting Rights
Direct
Indirect
xi
Direct
xii
Indirect
Direct
Indirect
GB0032350695
850,273
850,273
1,146,456
1,146,456
5.6271%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration date xiii
Exercise/
Conversion Period xiv
Number of voting
rights that may be acquired if the instrument is exercised/ converted.
% of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise
price
Expiration date xvii
Exercise/
Conversion period xviii
Number of voting rights
instrument refers to
% of voting rights xix,
xx
Nominal
Delta
Total (A+B+C)
Number of voting rights
Percentage of voting rights
1,146,456
5.6271%
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
416,183 of these shares are held for unit trusts operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the portfolio of investments on a discretionary basis. The remaining balance is held on behalf of other discretionary clients.
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
Animalcare Group plc is a United Kingdom-based international veterinary sales and marketing company. The Company is focused on bringing products to market through its own development pipeline, partnerships and through acquisitions. The Company develops and commercializes prescription and over-the-counter pharmaceutical products that improve animal health and wellbeing. These are developed in-house, acquired from other companies or in-licensed from its partners. The Company manages an international supply chain, including specialist veterinary wholesalers and distributors. It partners with companies to commercialize products across Europe. The Company operates in three categories within the veterinary market: companion animals, equine and other, and production animals. Its product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs. The Company operates in seven countries and exports to about 40 countries in Europe and worldwide.